ILMN Illumina Inc Price Chart

Brandmark of Illumina Corp (ILMN)

Illumina, Inc. (ILMN) dominates the genome sequencing sector, leveraging a sales model based on hardware and ancillary reagents, while the launch of NovaSeq X and the divestiture of GRAIL stimulate growth, which currently stands at 206.75. This daily price chart visualizes the price action of this tech giant. Despite internal crises, the company's systems remain the global benchmark as they enter a stage of mature competition.

Stock Quotes: Illumina, Inc. (ILMN) for 07/04/2022 - 11/16/2026

Metric breakdowns and analytics for Illumina Corp (ILMN)

- stock quotes and analyst forecast:
Analysis of all company metrics:Illumina Corp
Signature product of Illumina Inc

The price reflects the market equilibrium of supply and demand, reacting instantaneously to operational business changes. This indicator measures current capitalization, determining whether Illumina, Inc. (ILMN) complies with US exchange listing requirements. This is critical for Illumina, Inc. (ILMN) during its strategic pivot to defend its leadership in genome sequencing. Such a focus on the core segment should stabilize quotes. By analyzing market value dynamics, investors can assess the success of this restructuring.